文献速递生殖医学

大豆制品及大豆异黄酮摄入与卵巢储备的关系

Intake of soy products and soy isoflavones in relation to ovarian reserve.
PubMed 文献 · Fertil Steril · 2023-03-03

该横断面研究纳入2007至2019年某学术生育中心667名参与者,评估大豆食物和异黄酮摄入与窦卵泡计数(AFC)、抗苗勒管激素(AMH)及卵泡刺激素(FSH)的关系。多变量模型未发现大豆摄入与AFC或月经周期第3天FSH相关,但最高大豆摄入组AMH水平显著较低(-1.16,95%CI:-1.92,-0.41)。结论认为在观察摄入范围内,大豆或异黄酮摄入与卵巢储备无强正相关或负相关。

要点

  • 多变量模型未发现大豆食物摄入与AFC或月经周期第3天FSH水平相关。
  • 最高大豆摄入类别参与者AMH水平显著较低(-1.16,95%CI:-1.92,-0.41)。
  • 敏感性分析中大豆摄入与AFC、AMH或FSH均无关联。

核心结论

  • 研究结果与大豆或异黄酮摄入在观察范围内与卵巢储备存在强正相关或负相关不一致,该摄入范围与美国一般人群有实质性重叠。

研究设计与样本

  • 横断面研究,纳入2007至2019年某学术生育中心667名参与者,报告大豆食物摄入并接受AFC评估。
  • 基线获取既往3个月15种大豆基食物摄入并估算异黄酮摄入,按大豆食物和异黄酮摄入分为5组,不摄入大豆者为参照组。
  • 主要结局为AFC,次要结局为AMH和FSH;AFC于月经周期第3天测量,FSH和AMH于月经周期第3天及卵泡期血样中测量。
  • 采用泊松回归模型分析AFC,分位数回归模型分析AMH和月经周期第3天FSH,并校正混杂因素。

主要发现

  • 参与者中位年龄35.0岁,大豆摄入中位数0.09份/天,异黄酮摄入中位数1.78 mg/天。
  • 粗分析中AFC、AMH和FSH与大豆摄入无关。
  • 多变量模型中大豆食物摄入与AFC或月经周期第3天FSH水平无关联。
  • 最高大豆食物摄入类别参与者AMH水平显著较低(-1.16,95%CI:-1.92,-0.41)。
  • 敏感性分析(采用不同大豆摄入切点、排除摄入最高2.5百分位参与者、额外校正饮食模式)中大豆摄入与AFC、AMH或FSH均无关联。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the association between intake of soy food and isoflavone with ovarian reserve. Previous studies suggest on the relationship between soy intake and human fertility are inconsistent. Some clinical studies suggest that soy and phytoestrogens may not be deleterious to reproduction and may even be beneficial in couples undergoing infertility treatment. However, no studies have evaluated the relationship between soy or isoflavone intake with markers of ovarian reserve other than follicle-stimulating hormone (FSH). DESIGN: Cross-sectional study. SETTING: An academic fertility center. PATIENT(S): Patients presenting to an academic fertility center between 2007 and 2019 were invited to participate in the Environment and Reproductive Health Study. INTERVENTION(S): Six hundred and sixty seven participants reported their soy food intake and had an antral follicle count (AFC) assessment. Intake of 15 soy-based foods during the previous 3 months was obtained at baseline and intake of isoflavone was estimated. Participants were divided into 5 groups based on soy food and isoflavone intake considering those who did not consume soy as the reference group. MAIN OUTCOME MEASURE(S): Ovarian reserve was assessed using AFC as the primary outcome measure, with antimüllerian hormone (AMH) and FSH as secondary outcome measures. The AFC was measured on the third day of the menstrual cycle. Moreover, FSH and AMH levels were measured in blood samples obtained on the third day and the follicular phase of the menstrual cycle. To evaluate the association between soy intake and ovarian reserve, we used Poisson regression models for AFC and quantile regression models for AMH and day 3 FSH levels by adjusting for confounders. RESULT(S): Participants had a median age of 35.0 years. The median intake of soy was 0.09 servings/day and isoflavones was 1.78 mg/day. Moreover, AFC, AMH, and FSH were unrelated to soy intake in crude analyses. We found no association between soy food intake with AFC or day 3 FSH level in multivariable models. However, participants in the highest category of soy food intake had significantly low AMH levels (-1.16, 95% confidence interval: -1.92, -0.41). Soy intake had no association with AFC, AMH, or FSH in sensitivity analyses that included using different cutoff points of soy intake, excluding participants in the highest 2.5 percentile of intake, and additional statistical adjustment for dietary patterns. CONCLUSION(S): The results of this study are not consistent with a strong positive or inverse association of soy or isoflavone intakes within the observed range of intake, which substantially overlaps with that in the general population of the United States as well as the ovarian reserve among individuals presenting to fertility centers.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Mitsunami M, Mínguez-Alarcón L, Florio AA, et al. Intake of soy products and soy isoflavones in relation to ovarian reserve. Fertil Steril. 2023. PMID: 36871859. doi:10.1016/j.fertnstert.2023.02.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。